Malignant triton tumor with thoracic region as the initial presentation: a case report
Frontiers in Oncology · 27.03.2026 · 16
DOI: 10.3389/fonc.2026.1764543 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 27.03.2026. Verfasst von Hang Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Malignant Triton Tumor (MTT) is a rare, highly aggressive peripheral nerve sheath tumor characterized by rhabdomyoblastic differentiation, seldom occurring primarily in the thoracic cavity. This report presents a rare case of MTT initially manifesting as chest pain, and reviews relevant literature to summarize its clinical features and therapeutic strategies.
Methods
A 23-year-old woman experienced chest pain for ten days and her condition worsened within 3 days. The patient had a known history of neurofibromatosis type 1 (NF1) and exhibited classic café-au-lait spots on physical examination. Diagnosis was confirmed via chest CTA, PET-CT, bronchoscopy, ultrasound, and histopathology. After surgical resection, the tumor recurred rapidly, prompting multiple treatments including chemotherapy, targeted therapy, and combination immunotherapy.
Results
Pathology after right lower lobectomy and chest wall resection confirmed MTT (S-100+/Desmin+/Myogenin+). Recurrence in the mediastinum was detected two months postoperatively. Disease stabilization was achieved using cadonilimab, apatinib, and ifosfamide/etoposide. Notably, the first application of single-cell RNA sequencing (scRNA-seq) in MTT, combined with the CopyKAT algorithm, distinguished malignant from non-malignant cells and revealed a heterogeneous tumor microenvironment composed of distinct functional cell populations, highlighting the tumor’s high degree of heterogeneity.
Conclusion
This case underscores the importance of considering MTT in young NF1 patients presenting with intrathoracic masses. An individualized, multimodal treatment approach may extend survival. scRNA-seq provides valuable insights into the molecular landscape of MTT and hold promise for guiding precision therapy in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
- Department of Translational Medicine, Amoy Diagnostics Co., Ltd, Xiamen, China.
Zitieren
APA
Yin, H., Zhang, X., Huang, Z., Zhang, X., Li, Q., Hu, T., Shi, X., Zhu, C., & Wei, H. (2026). Malignant triton tumor with thoracic region as the initial presentation: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1764543
Vancouver
Yin H, Zhang X, Huang Z, Zhang X, Li Q, Hu T, et al. Malignant triton tumor with thoracic region as the initial presentation: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1764543
BibTeX
@article{Yin2026,
author = {Yin, Hang and Zhang, Xindi and Huang, Zhan and Zhang, Xiaotian and Li, Qian and Hu, Tao and Shi, Xiaoliang and Zhu, Changbin and Wei, Huabing},
title = {Malignant triton tumor with thoracic region as the initial presentation: a case report},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1764543}
}
EUVIMED